Matthew Brams
Oprichter bij CINGULATE INC.
Vermogen: 27 310 $ op 30-04-2024
Profiel
Matthew N.
Brams is the founder of Cingulate Works, Inc. (2013) and Cingulate, Inc. (2013), where he holds the title of Chief Medical Officer & Executive Vice President.
Currently, he is a Clinical Associate Professor at Baylor College of Medicine.
Previously, he worked as the Medical Director & Principal at Bayou City Research, Inc. (1999-2021).
He received his undergraduate degree from The University of Texas at Austin and his doctorate from the University of Texas Health Science Center at Houston.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CINGULATE, INC.
0.82% | 15-04-2024 | 32 512 ( 0.82% ) | 27 310 $ | 30-04-2024 |
Actieve functies van Matthew Brams
| Bedrijven | Functie | Begin |
|---|---|---|
| CINGULATE INC. | Oprichter | 01-01-2013 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Oprichter | - |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Oprichter | 01-01-2013 |
| Baylor College of Medicine | Corporate Officer/Principal | - |
Eerdere bekende functies van Matthew Brams
| Bedrijven | Functie | Einde |
|---|---|---|
| Bayou City Research, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Opleiding van Matthew Brams
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Health Science Center at Houston | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Bayou City Research, Inc. |